The recommendations were made during the 66th DCC meeting, held on June 17, 2025, at CDSCO headquarters, New Delhi, under the chairmanship of Dr Rajeev Singh Raghuvanshi, Drugs Controller General (India). Unregulated Access in Private Sector Raises Red …

Novo Nordisk filed for two patent applications in India—in 2006, … ’s has challenged the second patent, contending that it lacks novelty … day a drug goes off patent," said Nimish Mehta, … play. Nonetheless, some doctors fear misuse of the drug because of …

… active patent term, there have been zero reported cases of misuse,” he … . We simply won’t allow patent evergreening after the protected term …

… in scientists and the alleged misuse of scientific information by federal … policies. Still, examiners and administrative patent judges use scientific information to … the agency during examination of patent applications. For Applicants Applicant-generated …

… patent No. 12,318,492 for its“Abuse and Misuse … Aversa(TM) technology. The patent, issued June 3, 2025, … transdermal products designed to curb misuse, diversion, and accidental exposure … to prevent the abuse, misuse, diversion, and accidental exposure …

… that the United States Patent and Trademark Office (USPTO … Misuse Deterrent Transdermal Systems." The issuance of this patent … prevent the abuse, diversion, misuse, and accidental exposure of … its ability to obtain patent protection for its abuse …

… may commit patent misuse.[2] Patent misuse is an affirmative defense to patent infringement, and … post-expiration royalties can constitute patent misuse, which has both long- … the minimum royalty provision constituted patent misuse under Brulotte, based on …

… Committee (SJTMC) Monday decided to patent certain words and logos associated … SJTA will soon apply to patent terms like Mahaprasad (bhog), … . “This will help prevent misuse of the 12th century’s … Bengal government over the alleged misuse of the term Jagannath …

… , and communications with patent examiners. Now, users — including patent attorneys, agents, and … risk of data breaches or misuse. Several federal audits and congressional … identity verification when accessing the Patent Center. As USPTO continues to …

… products, has been granted a patent in Macao for its AVERSATM … transdermal technology. The patent, titled“Abuse and Misuse Deterrent Transdermal Systems,” was … patch to prevent the abuse, misuse, diversion, and accidental exposure of …